. abbvie to CoDevelop Teneobios Lead Candidate for Multiple Myeloma Gains Acquisition Option httpow.ly1vNp30nESUjÂpic.twitter.comL9McahSldG
. @abbvie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option: http://ow.ly/1vNp30nESUj pic.twitter.com/L9McahSldG
More From BioPortfolio on ". @abbvie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition Option: http://ow.ly/1vNp30nESUj pic.twitter.com/L9McahSldG"